We will contribute ourselves to
the health and well being of
people by creating new value.

What's New

Clinical Pipeline

NC-6004

Cisplatin micelle

Head and Neck cancer

phaseⅠ phaseⅡ phaseⅢ

VB-111

(In-Licensed) Non-replicating Adeno 5 vectors

Ovarian cancer

phaseⅠ phaseⅡ phaseⅢ

Business for Drug Discovery